News
Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) ...
Jeremy Bender; President, Chief Executive Officer, Director; Day One Biopharmaceuticals Inc Lauren Merendino; Chief Commercial Officer; Day One Biopharmaceuticals Inc Charles York; Chief Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback